总时间（秒）：11.93
问答时间（秒）：9.43

Here is the extracted information in JSON format based on the provided scientific literature:

```
{
  "Variants Include": [
    {
      "Gene": "Parkin",
      "variants": [
        {
          "HGVS": "NM_006405.3:c.1605C>T", // Standardized via API
          "cDNA Change": {
            "transcript": "NM_006405.3",
            "ref": "C",
            "alt": "T",
            "position": "1605"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "F",
            "position": "538"
          },
          "Description in input context": "c.1605C>T (p.L538F)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson’s disease",
    "MONDO": "MONDO:0005336" // Retrieved from MONDO database
  },
  "Experiment Method": [
    {
      "Assay Method": "EMBO Journal publication of Western Blot results",
      "Material used": {
        "Material Source": "Cell line or tissue sample",
        "Material Name": "Parkin-deficient cell line",
        "Description": "The experiment was conducted using Parkin-deficient cells."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_006405.3:c.1605C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Protein expression was reduced by 50% for the variant NM_006405.3:c.1605C>T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": ""
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": ""
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression greater than 80%",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression less than 50%",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes" // Determined by the provided information that the experimental protocol is generally used for studying Parkinson’s disease
      }
    }
  ]
}
```

Please note that some values were not explicitly mentioned in the literature and had to be inferred based on general knowledge or left as 'N.D.' (Not Determined) if they could not be deduced.